Emily Pepe, NP
Adult Health · San Francisco, CANPI 1134760176
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Seagen Inc. accounts for 87.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $11,252 and has fallen 99.7% since, to $38 in 2025. Among adult health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $292.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$11K
- AstraZeneca$712
- Pfizer$513
- Amgen$122
- Genentech USA, Inc.$111
- Bristol Myers Squibb$38
- plus $30 from 1 others
What the payments were for
- Speaking & faculty fees$6,18550%
- Travel & lodging$4,28435%
- Food & beverage$1,67314%
- Education$1621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 25 | $10,777 |
| AstraZeneca | 8 | $712 |
| Pfizer | 5 | $513 |
| Amgen | 1 | $122 |
| Genentech USA, Inc. | 1 | $111 |
| Bristol Myers Squibb | 1 | $38 |
| Daiichi Sankyo Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,304 in reported general payments places this provider in the 95th percentile of 785 adult health providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 42 | $1,001 |
| Levothyroxine Sodium | 60 | $599 |
| Prednisone | 63 | $546 |
| Triamcinolone Acetonide | 16 | $190 |
| Omeprazole | 13 | $123 |
Paid to pharmacies, not to this prescriber.
Other adult health in San Francisco
- Stephany RodriguezSan Francisco$27K
- Sarah DonahueSan Francisco$9K
- Dirk CollevecchioSan Francisco$7K
- Karolina FaysmanLos Angeles$1.1M
- Linda BuckLos Angeles$170K
- Naomi PesynaAnaheim$141K
- Stacy GrissenEncinitas$82K
- Kimberly PodsadaSan Diego$78K
- Brenda PatrickSan Leandro$68K
- Brittany PolizziEncinitas$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.